AU1756299A - Use of putamen ovi - Google Patents
Use of putamen oviInfo
- Publication number
- AU1756299A AU1756299A AU17562/99A AU1756299A AU1756299A AU 1756299 A AU1756299 A AU 1756299A AU 17562/99 A AU17562/99 A AU 17562/99A AU 1756299 A AU1756299 A AU 1756299A AU 1756299 A AU1756299 A AU 1756299A
- Authority
- AU
- Australia
- Prior art keywords
- putamen ovi
- ovi
- putamen
- medicaments
- locally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Paper (AREA)
Abstract
The invention relates to the use of treated putamen ovi in the production of medicaments which can be administered orally or locally for treatment and prevention.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19751681 | 1997-11-21 | ||
DE19751681A DE19751681A1 (en) | 1997-11-21 | 1997-11-21 | Use of Putamen ovi |
PCT/EP1998/007477 WO1999026641A1 (en) | 1997-11-21 | 1998-11-20 | Use of putamen ovi |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1756299A true AU1756299A (en) | 1999-06-15 |
Family
ID=7849459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17562/99A Abandoned AU1756299A (en) | 1997-11-21 | 1998-11-20 | Use of putamen ovi |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1032407B1 (en) |
AT (1) | ATE249229T1 (en) |
AU (1) | AU1756299A (en) |
CA (1) | CA2311546A1 (en) |
DE (2) | DE19751681A1 (en) |
DK (1) | DK1032407T3 (en) |
ES (1) | ES2207020T3 (en) |
WO (1) | WO1999026641A1 (en) |
ZA (1) | ZA9810603B (en) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558771A (en) * | 1968-02-12 | 1971-01-26 | Leslie L Balassa | Process for using eggshell compositions for promoting wound healing |
GB2218906A (en) * | 1988-05-27 | 1989-11-29 | Anne Mcmanus | Medicament for treatment of skin disorders |
CS445488A1 (en) * | 1988-06-24 | 1991-01-15 | Karol Mvdr Michalek | Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment |
CN1079149A (en) * | 1993-04-09 | 1993-12-08 | 李洪洋 | A kind of biological calcium element and preparation method thereof |
DE4422613A1 (en) * | 1994-06-28 | 1996-01-04 | Aar Pharma Adler Apotheke | Putamen ovi |
NL1002400C2 (en) * | 1996-02-20 | 1997-08-21 | Friesland Brands Bv | Oral calcitonin preparation and method of recovering calcitonin. |
DE19627376A1 (en) * | 1996-07-06 | 1998-01-08 | Aar Pharma Adler Apotheke | Use of Artichoke (Cynara) extracts |
DE19639375A1 (en) * | 1996-09-25 | 1998-04-02 | Aar Pharma | Mistletoe dry extracts |
DE19700788A1 (en) * | 1997-01-11 | 1998-07-16 | Michael O Ruepp | Use of a dry extract of St. John's wort |
-
1997
- 1997-11-21 DE DE19751681A patent/DE19751681A1/en not_active Withdrawn
-
1998
- 1998-11-19 ZA ZA9810603A patent/ZA9810603B/en unknown
- 1998-11-20 DK DK98962374T patent/DK1032407T3/en active
- 1998-11-20 AU AU17562/99A patent/AU1756299A/en not_active Abandoned
- 1998-11-20 AT AT98962374T patent/ATE249229T1/en active
- 1998-11-20 CA CA002311546A patent/CA2311546A1/en not_active Abandoned
- 1998-11-20 ES ES98962374T patent/ES2207020T3/en not_active Expired - Lifetime
- 1998-11-20 DE DE59809592T patent/DE59809592D1/en not_active Expired - Lifetime
- 1998-11-20 WO PCT/EP1998/007477 patent/WO1999026641A1/en active IP Right Grant
- 1998-11-20 EP EP98962374A patent/EP1032407B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1032407B1 (en) | 2003-09-10 |
ES2207020T3 (en) | 2004-05-16 |
EP1032407A1 (en) | 2000-09-06 |
ZA9810603B (en) | 1999-08-02 |
DE59809592D1 (en) | 2003-10-16 |
DK1032407T3 (en) | 2004-01-12 |
ATE249229T1 (en) | 2003-09-15 |
DE19751681A1 (en) | 1999-07-29 |
CA2311546A1 (en) | 1999-06-03 |
WO1999026641A1 (en) | 1999-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267381A (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | |
NO954996D0 (en) | Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS | |
HU9603042D0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration | |
MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
WO1995031991A3 (en) | Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases | |
WO1998026770A3 (en) | The topical use of kappa opioid agonists to treat ocular pain | |
CA2418167A1 (en) | Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses | |
MY117918A (en) | Use of an h+, k+- atpase inhibitor in the treatment of nasal polyps | |
GB0020504D0 (en) | Therapeutic method | |
PL338673A1 (en) | Application of fanquinone in treating alzheimer disease | |
NZ326345A (en) | Composition containing diosgenin | |
NZ533309A (en) | Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission | |
NO990450L (en) | Treatment of mental disorders | |
AU1756299A (en) | Use of putamen ovi | |
WO2000061125A3 (en) | Osanetant in the treatment of mood disorders | |
PL329219A1 (en) | Application of benzonaphtene derivatives in production of drugs for treating nervous system diseases | |
AU2811400A (en) | Stable formulation containing fumagillin | |
AU6004300A (en) | Treatment of angiogenesis dependent conditions with dextrin sulphate | |
AU2003255429A1 (en) | Use of treosulfan and derivatives thereof for treating multiple sclerosis | |
UA32580C2 (en) | Drug for treatment of paralytic intestinal obstructioni | |
WO2000067733A3 (en) | Medicament for treating human infertility | |
MX9605327A (en) | Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration. | |
UA27148C2 (en) | Method for treating acute pyelonephritis | |
MD1664G2 (en) | Method of ulcer recidivation prophylaxis | |
MD950122A (en) | Method of treatment of depressive state for oncological postinsult ill people |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |